Novel investigational drugs active as single agents in multiple myeloma-Reference-Cited by-同舟云学术

Novel investigational drugs active as single agents in multiple myeloma

Published:2017-05-08 Issue:6 Volume:26 Page:699-711
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

D’Agostino Mattia¹,Salvini Marco¹,Palumbo Antonio¹²,Larocca Alessandra¹,Gay Francesca¹

Affiliation:

1. Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy

2. Currently Takeda employee

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543784.2017.1324571

Reference108 articles.

1. Multiple myeloma: 2016 update on diagnosis, risk-stratification, and management

2. Epidemiology of Multiple Myeloma

3. Patterns of Multiple Myeloma During the Past 5 Decades: Stable Incidence Rates for All Age Groups in the Population but Rapidly Changing Age Distribution in the Clinic

4. Multiple Myeloma

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural variety and pharmacological potential of naphthylisoquinoline alkaloids;The Alkaloids: Chemistry and Biology;2024

2. An overview of pim kinase as a target in multiple myeloma;Cancer Medicine;2023-05

3. A phase 2 clinical trial of combined BRAF/MEK inhibition for BRAFV600E-mutated multiple myeloma;Blood;2023-04-06

4. Management of Renal Failure in Multiple Myeloma;Recent Updates on Multiple Myeloma;2023-03-15

5. Innovative Anti-CD38 and Anti-BCMA Targeted Therapies in Multiple Myeloma: Mechanisms of Action and Resistance;International Journal of Molecular Sciences;2022-12-30